25 XP   0   0   10

Elixxer Ltd
Buy, Hold or Sell?

Let's analyse Elixxer together

PenkeI guess you are interested in Elixxer Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Elixxer Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Elixxer Ltd

I send you an email if I find something interesting about Elixxer Ltd.

Quick analysis of Elixxer (30 sec.)










What can you expect buying and holding a share of Elixxer? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.36
Expected worth in 1 year
$-4.15
How sure are you?
55.6%

+ What do you gain per year?

Total Gains per Share
$-3.79
Return On Investment
-62,144.3%

For what price can you sell your share?

Current Price per Share
$0.01
Expected price per share
$0 - $0.0165
How sure are you?
50%

1. Valuation of Elixxer (5 min.)




Live pricePrice per Share (EOD)

$0.01

Intrinsic Value Per Share

$-2.23 - $0.70

Total Value Per Share

$-2.60 - $0.34

2. Growth of Elixxer (5 min.)




Is Elixxer growing?

Current yearPrevious yearGrowGrow %
How rich?-$4.1m$6.6m-$10.7m-260.8%

How much money is Elixxer making?

Current yearPrevious yearGrowGrow %
Making money-$7.6m-$2.1m-$5.5m-72.3%
Net Profit Margin-12,730.3%-6,827.6%--

How much money comes from the company's main activities?

3. Financial Health of Elixxer (5 min.)




What can you expect buying and holding a share of Elixxer? (5 min.)

Welcome investor! Elixxer's management wants to use your money to grow the business. In return you get a share of Elixxer.

What can you expect buying and holding a share of Elixxer?

First you should know what it really means to hold a share of Elixxer. And how you can make/lose money.

Speculation

The Price per Share of Elixxer is $0.0061. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Elixxer.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Elixxer, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.36. Based on the TTM, the Book Value Change Per Share is $-0.95 per quarter. Based on the YOY, the Book Value Change Per Share is $0.25 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Elixxer.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.91-14,949.4%-0.91-14,949.4%-0.24-3,863.6%-0.61-9,927.3%-0.40-6,532.4%
Usd Book Value Change Per Share-0.95-15,536.1%-0.95-15,536.1%0.254,179.5%-0.07-1,210.9%-0.04-661.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.95-15,536.1%-0.95-15,536.1%0.254,179.5%-0.07-1,210.9%-0.04-661.8%
Usd Price Per Share0.80-0.80-0.90-4.20-2.33-
Price to Earnings Ratio-0.88--0.88--3.82--83.45--46.36-
Price-to-Total Gains Ratio-0.84--0.84-3.53-64.94-64.94-
Price to Book Ratio-2.20--2.20-1.54-56.63-31.46-
Price-to-Total Gains Ratio-0.84--0.84-3.53-64.94-64.94-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0061
Number of shares163934
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.95-0.07
Usd Total Gains Per Share-0.95-0.07
Gains per Quarter (163934 shares)-155,360.45-12,108.64
Gains per Year (163934 shares)-621,441.79-48,434.55
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-621442-6214520-48435-48445
20-1242884-12428940-96869-96880
30-1864325-18643360-145304-145315
40-2485767-24857780-193738-193750
50-3107209-31072200-242173-242185
60-3728651-37286620-290607-290620
70-4350093-43501040-339042-339055
80-4971534-49715460-387476-387490
90-5592976-55929880-435911-435925
100-6214418-62144300-484345-484360

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.09.00.00.0%0.09.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%5.04.00.055.6%5.04.00.055.6%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.09.00.0%0.00.09.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%5.04.00.055.6%5.04.00.055.6%

Fundamentals of Elixxer

About Elixxer Ltd

Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It invests in cultivation, production, and/or sale of medical cannabis and cannabis-derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. Elixxer Ltd. was incorporated in 2004 and is based in Montreal, Canada.

Fundamental data was last updated by Penke on 2024-04-25 12:15:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Elixxer Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Elixxer earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Elixxer to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -12,730.3% means that $-127.30 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Elixxer Ltd:

  • The MRQ is -12,730.3%. The company is making a huge loss. -2
  • The TTM is -12,730.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-12,730.3%TTM-12,730.3%0.0%
TTM-12,730.3%YOY-6,827.6%-5,902.7%
TTM-12,730.3%5Y-20,104.8%+7,374.5%
5Y-20,104.8%10Y-13,089.8%-7,015.0%
1.1.2. Return on Assets

Shows how efficient Elixxer is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Elixxer to the Drug Manufacturers - Specialty & Generic industry mean.
  • -192.6% Return on Assets means that Elixxer generated $-1.93 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Elixxer Ltd:

  • The MRQ is -192.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -192.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-192.6%TTM-192.6%0.0%
TTM-192.6%YOY-15.9%-176.8%
TTM-192.6%5Y-67.1%-125.6%
5Y-67.1%10Y-73.7%+6.7%
1.1.3. Return on Equity

Shows how efficient Elixxer is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Elixxer to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Equity means Elixxer generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Elixxer Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-31.9%+31.9%
TTM-5Y-59.2%+59.2%
5Y-59.2%10Y-392.9%+333.8%

1.2. Operating Efficiency of Elixxer Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Elixxer is operating .

  • Measures how much profit Elixxer makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Elixxer to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Elixxer Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-3,909.4%+3,909.4%
TTM-5Y-10,447.8%+10,447.8%
5Y-10,447.8%10Y-7,722.7%-2,725.2%
1.2.2. Operating Ratio

Measures how efficient Elixxer is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 22.51 means that the operating costs are $22.51 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Elixxer Ltd:

  • The MRQ is 22.510. The company is inefficient in keeping operating costs low. -1
  • The TTM is 22.510. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ22.510TTM22.5100.000
TTM22.510YOY39.094-16.584
TTM22.5105Y121.169-98.659
5Y121.16910Y82.326+38.843

1.3. Liquidity of Elixxer Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Elixxer is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.34 means the company has $0.34 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Elixxer Ltd:

  • The MRQ is 0.344. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.344. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.344TTM0.3440.000
TTM0.344YOY1.620-1.276
TTM0.3445Y0.918-0.574
5Y0.91810Y14.929-14.011
1.3.2. Quick Ratio

Measures if Elixxer is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Elixxer to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.67 means the company can pay off $0.67 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Elixxer Ltd:

  • The MRQ is 0.672. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.672. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.672TTM0.6720.000
TTM0.672YOY3.191-2.519
TTM0.6725Y0.870-0.198
5Y0.87010Y4.619-3.749

1.4. Solvency of Elixxer Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Elixxer assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Elixxer to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 2.04 means that Elixxer assets are financed with 204.1% credit (debt) and the remaining percentage (100% - 204.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Elixxer Ltd:

  • The MRQ is 2.041. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 2.041. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ2.041TTM2.0410.000
TTM2.041YOY0.502+1.538
TTM2.0415Y0.742+1.298
5Y0.74210Y0.574+0.168
1.4.2. Debt to Equity Ratio

Measures if Elixxer is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Elixxer to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Elixxer Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY1.009-1.009
TTM-5Y0.978-0.978
5Y0.97810Y3.203-2.225

2. Market Valuation of Elixxer Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Elixxer generates.

  • Above 15 is considered overpriced but always compare Elixxer to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -0.88 means the investor is paying $-0.88 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Elixxer Ltd:

  • The EOD is -0.007. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.877. Based on the earnings, the company is expensive. -2
  • The TTM is -0.877. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.007MRQ-0.877+0.871
MRQ-0.877TTM-0.8770.000
TTM-0.877YOY-3.819+2.942
TTM-0.8775Y-83.450+82.573
5Y-83.45010Y-46.361-37.089
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Elixxer Ltd:

  • The EOD is -0.043. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -5.579. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.579. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.043MRQ-5.579+5.537
MRQ-5.579TTM-5.5790.000
TTM-5.579YOY-4.402-1.177
TTM-5.5795Y-298.404+292.824
5Y-298.40410Y-165.780-132.624
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Elixxer is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Elixxer Ltd:

  • The EOD is -0.017. Based on the equity, the company is expensive. -2
  • The MRQ is -2.202. Based on the equity, the company is expensive. -2
  • The TTM is -2.202. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.017MRQ-2.202+2.185
MRQ-2.202TTM-2.2020.000
TTM-2.202YOY1.540-3.742
TTM-2.2025Y56.626-58.827
5Y56.62610Y31.459+25.167
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Elixxer Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.948-0.9480%0.255-472%-0.074-92%-0.040-96%
Book Value Per Share---0.363-0.3630%0.584-162%0.398-191%0.377-196%
Current Ratio--0.3440.3440%1.620-79%0.918-63%14.929-98%
Debt To Asset Ratio--2.0412.0410%0.502+306%0.742+175%0.574+255%
Debt To Equity Ratio----0%1.009-100%0.978-100%3.203-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.912-0.9120%-0.236-74%-0.606-34%-0.398-56%
Free Cash Flow Per Share---0.143-0.1430%-0.204+43%-0.158+10%-0.133-7%
Free Cash Flow To Equity Per Share---0.121-0.1210%-0.203+67%0.011-1166%0.010-1348%
Gross Profit Margin--1.0351.0350%1.141-9%1.061-2%1.034+0%
Intrinsic Value_10Y_max--0.703--------
Intrinsic Value_10Y_min---2.233--------
Intrinsic Value_1Y_max---0.109--------
Intrinsic Value_1Y_min---0.183--------
Intrinsic Value_3Y_max---0.190--------
Intrinsic Value_3Y_min---0.588--------
Intrinsic Value_5Y_max---0.107--------
Intrinsic Value_5Y_min---1.033--------
Market Cap69167.290-13015%9071120.0009071120.0000%10205010.000-11%999513711.780-99%555285395.433-98%
Net Profit Margin---127.303-127.3030%-68.276-46%-201.048+58%-130.898+3%
Operating Margin----0%-39.0940%-104.4780%-77.2270%
Operating Ratio--22.51022.5100%39.094-42%121.169-81%82.326-73%
Pb Ratio-0.017+99%-2.202-2.2020%1.540-243%56.626-104%31.459-107%
Pe Ratio-0.007+99%-0.877-0.8770%-3.819+335%-83.450+9412%-46.361+5185%
Price Per Share0.006-13015%0.8000.8000%0.900-11%4.200-81%2.333-66%
Price To Free Cash Flow Ratio-0.043+99%-5.579-5.5790%-4.402-21%-298.404+5249%-165.780+2871%
Price To Total Gains Ratio-0.006+99%-0.844-0.8440%3.530-124%64.943-101%64.943-101%
Quick Ratio--0.6720.6720%3.191-79%0.870-23%4.619-85%
Return On Assets---1.926-1.9260%-0.159-92%-0.671-65%-0.737-62%
Return On Equity----0%-0.3190%-0.5920%-3.9290%
Total Gains Per Share---0.948-0.9480%0.255-472%-0.074-92%-0.040-96%
Usd Book Value---4119966.000-4119966.0000%6625923.000-162%7937602.000-152%6346411.667-165%
Usd Book Value Change Per Share---0.948-0.9480%0.255-472%-0.074-92%-0.040-96%
Usd Book Value Per Share---0.363-0.3630%0.584-162%0.398-191%0.377-196%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.912-0.9120%-0.236-74%-0.606-34%-0.398-56%
Usd Free Cash Flow---1625901.197-1625901.1970%-2318252.928+43%-2443523.497+50%-1572885.948-3%
Usd Free Cash Flow Per Share---0.143-0.1430%-0.204+43%-0.158+10%-0.133-7%
Usd Free Cash Flow To Equity Per Share---0.121-0.1210%-0.203+67%0.011-1166%0.010-1348%
Usd Market Cap69167.290-13015%9071120.0009071120.0000%10205010.000-11%999513711.780-99%555285395.433-98%
Usd Price Per Share0.006-13015%0.8000.8000%0.900-11%4.200-81%2.333-66%
Usd Profit---7627907.443-7627907.4430%-2112730.445-72%-6924650.673-9%-4942226.658-35%
Usd Revenue--59919.13059919.1300%30943.795+94%58037.637+3%32446.366+85%
Usd Total Gains Per Share---0.948-0.9480%0.255-472%-0.074-92%-0.040-96%
 EOD+2 -6MRQTTM+0 -0YOY+11 -215Y+9 -2310Y+7 -25

3.2. Fundamental Score

Let's check the fundamental score of Elixxer Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.007
Price to Book Ratio (EOD)Between0-1-0.017
Net Profit Margin (MRQ)Greater than0-127.303
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.672
Current Ratio (MRQ)Greater than10.344
Debt to Asset Ratio (MRQ)Less than12.041
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.926
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Elixxer Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.006
Total0/1 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-09-302019-09-302020-09-302021-09-302022-09-30
Total Stockholder Equity 17,674-1,90115,773-12,0383,7352,8916,626-10,746-4,120



Latest Balance Sheet

Balance Sheet of 2022-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets3,960
Total Liabilities8,080
Total Stockholder Equity-4,120
 As reported
Total Liabilities 8,080
Total Stockholder Equity+ -4,120
Total Assets = 3,960

Assets

Total Assets3,960
Total Current Assets1,863
Long-term Assets2,096
Total Current Assets
Cash And Cash Equivalents 48
Short-term Investments 1,775
Net Receivables 41
Total Current Assets  (as reported)1,863
Total Current Assets  (calculated)1,863
+/-0
Long-term Assets
Long Term Investments 2,841
Long-term Assets  (as reported)2,096
Long-term Assets  (calculated)2,841
+/- 745

Liabilities & Shareholders' Equity

Total Current Liabilities5,415
Long-term Liabilities2,664
Total Stockholder Equity-4,120
Total Current Liabilities
Short-term Debt 3,253
Short Long Term Debt 4,410
Accounts payable 2,088
Other Current Liabilities 74
Total Current Liabilities  (as reported)5,415
Total Current Liabilities  (calculated)9,825
+/- 4,410
Long-term Liabilities
Long term Debt 3,612
Long-term Liabilities  (as reported)2,664
Long-term Liabilities  (calculated)3,612
+/- 947
Total Stockholder Equity
Common Stock39,426
Retained Earnings -59,387
Accumulated Other Comprehensive Income 2,981
Other Stockholders Equity 12,860
Total Stockholder Equity (as reported)-4,120
Total Stockholder Equity (calculated)-4,120
+/-0
Other
Capital Stock53,445
Cash and Short Term Investments 1,823
Common Stock Shares Outstanding 11,196
Current Deferred Revenue0
Liabilities and Stockholders Equity 3,960
Net Debt 5,869
Net Invested Capital 2,437
Net Working Capital -4,814
Short Long Term Debt Total 5,917



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-09-302021-09-302020-09-302019-12-312019-09-302018-09-302017-09-302016-09-302016-06-302015-09-30
> Total Assets 
8,366
260
8,055
2,747
20,738
21,031
0
16,338
13,310
3,960
3,96013,31016,338021,03120,7382,7478,0552608,366
   > Total Current Assets 
8,288
260
7,843
2,747
6,777
1,427
0
1,825
10,829
1,863
1,86310,8291,82501,4276,7772,7477,8432608,288
       Cash And Cash Equivalents 
6,573
233
486
2,019
6,566
245
0
1,651
239
48
482391,65102456,5662,0194862336,573
       Short-term Investments 
1,600
0
6,774
677
0
0
0
0
10,502
1,775
1,77510,50200006776,77401,600
       Net Receivables 
115
1
104
51
211
1,182
0
175
88
41
418817501,182211511041115
   > Long-term Assets 
0
0
211
0
13,961
19,604
0
14,512
2,481
2,096
2,0962,48114,512019,60413,961021100
       Property Plant Equipment 
0
0
0
0
10
6
8
4
0
0
00486100000
       Long Term Investments 
78
0
211
0
7,844
25,948
0
15,991
690
2,841
2,84169015,991025,9487,8440211078
       Other Assets 
0
0
0
0
2,698
0
396
0
0
0
00039602,6980000
> Total Liabilities 
75
249
503
1,171
3,064
5,258
0
12,603
6,684
8,080
8,0806,68412,60305,2583,0641,17150324975
   > Total Current Liabilities 
75
249
503
1,171
3,064
5,258
0
12,603
6,684
5,415
5,4156,68412,60305,2583,0641,17150324975
       Short-term Debt 
0
0
0
0
0
3,942
0
10,277
5,174
3,253
3,2535,17410,27703,94200000
       Short Long Term Debt 
0
20
0
325
2,529
0
0
13,093
6,545
4,410
4,4106,54513,093002,5293250200
       Accounts payable 
75
230
503
812
340
1,316
0
1,675
1,497
2,088
2,0881,4971,67501,31634081250323075
       Other Current Liabilities 
0
0
0
0
195
0
0
650
13
74
7413650001950000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
2,664
2,664000000000
> Total Stockholder Equity
8,291
11
7,551
1,576
17,674
15,773
0
3,735
6,626
-4,120
-4,1206,6263,735015,77317,6741,5767,551118,291
   Common Stock
8,400
0
11,213
13,108
32,336
35,716
48,964
38,910
42,104
39,426
39,42642,10438,91048,96435,71632,33613,10811,21308,400
   Retained Earnings -59,387-52,441-49,189-52,884-31,952-29,014-13,007-7,959-5,988-98
   Capital Surplus 0000000000
   Treasury Stock0000000000
   Other Stockholders Equity 
-11
0
3,248
-19
4,349
9,546
4,384
10,613
13,173
12,860
12,86013,17310,6134,3849,5464,349-193,2480-11



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2023-09-30)

Gross Profit (+$)
totalRevenue82
Cost of Revenue--
Gross Profit-82
 
Operating Income (+$)
Gross Profit-
Operating Expense-2,652
Operating Income-2,570-2,652
 
Operating Expense (+$)
Research Development-
Selling General Administrative2,365
Selling And Marketing Expenses-
Operating Expense2,6522,365
 
Net Interest Income (+$)
Interest Income25
Interest Expense-2,591
Other Finance Cost-0
Net Interest Income-2,566
 
Pretax Income (+$)
Operating Income-2,570
Net Interest Income-2,566
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-5,026-2,680
EBIT - interestExpense = -2,591
-5,108
-2,517
Interest Expense2,591
Earnings Before Interest and Taxes (EBIT)--2,435
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-5,026
Tax Provision--
Net Income From Continuing Ops-5,026-5,026
Net Income-5,108
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net1102,566
 

Technical Analysis of Elixxer
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Elixxer. The general trend of Elixxer is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Elixxer's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Elixxer Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.0165 < 0.0165 < 0.0165.

The bearish price targets are: .

Tweet this
Elixxer Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Elixxer Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Elixxer Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Elixxer Ltd.

Elixxer Ltd Daily Moving Average Convergence/Divergence (MACD) ChartElixxer Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Elixxer Ltd. The current adx is .

Elixxer Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Elixxer Ltd.

Elixxer Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Elixxer Ltd.

Elixxer Ltd Daily Relative Strength Index (RSI) ChartElixxer Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Elixxer Ltd.

Elixxer Ltd Daily Stochastic Oscillator ChartElixxer Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Elixxer Ltd.

Elixxer Ltd Daily Commodity Channel Index (CCI) ChartElixxer Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Elixxer Ltd.

Elixxer Ltd Daily Chande Momentum Oscillator (CMO) ChartElixxer Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Elixxer Ltd.

Elixxer Ltd Daily Williams %R ChartElixxer Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Elixxer Ltd.

Elixxer Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Elixxer Ltd.

Elixxer Ltd Daily Average True Range (ATR) ChartElixxer Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Elixxer Ltd.

Elixxer Ltd Daily On-Balance Volume (OBV) ChartElixxer Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Elixxer Ltd.

Elixxer Ltd Daily Money Flow Index (MFI) ChartElixxer Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Elixxer Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-04-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Elixxer Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Elixxer Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.006
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Elixxer with someone you think should read this too:
  • Are you bullish or bearish on Elixxer? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Elixxer? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Elixxer Ltd

I send you an email if I find something interesting about Elixxer Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Elixxer Ltd.

Receive notifications about Elixxer Ltd in your mailbox!